Glycyrrhetinic Acid

甘草次酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGlycyrrhetinic Acid
Drug Alias NameenoxolonaEnoxoloneenoxolonumGlycyrrhetic AcidHidermart +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors
TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1
Therapy Area/IndicationsDepressive DisorderInflammationPruritus +[6] 
Global Approved IndicationsInflammationPruritusNeurodermatitis +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1965/08/19
Country/TerritoryUnited StatesGermanyJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMinophagen Pharmaceutical Co LtdMayado PharmaceuticalMiyarisan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPhilipps University MarburgMayado PharmaceuticalMiyarisan Pharmaceutical Co Ltd
Inactive CompaniesThe Brigham and Women's Hospital
Active IndicationsDepressive DisorderInflammationPruritus +[5] 
Inactive IndicationsMineralocorticoid Excess Syndrome, Apparent

Other Information

ATC CodeD03AX10
Related LinksWikipediaKEGG